Book 1A-FDAE6R3: 2025 Selected Regulations & Guidance for Drug Studies <span style="color: #b70202">(With FDA/ICH GCP E6(R3))</span>Description Contents Cover This spiral bound, 5" x 7. 5" book is a compilation of FDA regulations and guidance documents that govern the conduct of clinical trials for drug research and submission of applications to FDA for marketing approval (NDAs). It includes all of 21 CFR Part 314 on NDAs and the ICH GCP Guideline E6(R3). Who Uses this Book and How? Clinical Research staff, as job aids Training departments, as training handouts Human Resources, as

•  Questions and Answers on Good Manufacturing Practices for Drugs

Investigations (46 FR 8958

research whose role requires compliance with Good Laboratory

including updates based on the December 2023 revisions to Part 493 that went into effect on December 28

6-1/2" x 8-1/2" book is a compilation of educational materials developed by the National Institutes of Health to assist research organizations and researchers in complying with the privacy provisions of the Health Insurance Portability and Accountability Act (HIPAA)

and Cellular and Tissue-Based Products (HCT/Ps)

Children Involved as Subjects in Research (As of April 1

When will Rave ALS 7

50   Protection of Human Subjects

• OSHA Regulations on handling of hazaradous laboratory chemicals

536/2014 on clinical trials on medicinal products for human use

• 1-249 copies:  $17